ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,930.80
      -2.19%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.93
      -1.55%
      Bitcoin
      60,094.16
      -5.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ascendis Pharma AS (ASND)

      7. Ascendis Pharma AS (ASND) News

      ASND Ascendis Pharma AS

      138.44
      -1.71 (-1.22%)
      After Hours
      Last Updated: 16:02:15
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Ascendis Pharma AS ASND NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -1.71 -1.22% 138.44 16:02:15
      Open Price Low Price High Price Close Price Prev Close
      139.88 137.00 141.47 138.44 140.15
      more quote information »

      Recent News

      Date Time Source Heading
      4/30/20248:53IHNWFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      4/25/202416:46GLOBEAscendis Pharma to Report First Quarter 2024 Financial..
      4/24/202408:30GLOBEUnited Kingdom’s MHRA Approves YORVIPATH®..
      3/07/202411:31EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202421:39EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202408:14EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202408:04EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202407:37EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202415:17EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202415:07EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202414:54EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202414:36EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202408:30GLOBEAscendis Pharma to Participate in the Leerink Partners..
      3/01/202411:00EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202417:13EDGAR2Form 144 - Report of proposed sale of securities
      2/28/202416:49EDGAR2Form 144 - Report of proposed sale of securities
      2/27/202417:45EDGAR2Form 144 - Report of proposed sale of securities
      2/21/202415:17EDGAR2Form 144 - Report of proposed sale of securities
      2/16/202417:16EDGAR2Form 144 - Report of proposed sale of securities
      2/16/202417:15EDGAR2Form 144 - Report of proposed sale of securities
      2/16/202417:14EDGAR2Form 144 - Report of proposed sale of securities
      2/14/202416:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/14/202411:40EDGAR2Form 144 - Report of proposed sale of securities
      2/14/202409:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/07/202416:15EDGAR2Form 20-F - Annual and transition report of foreign private..
      2/07/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/07/202416:01GLOBEAscendis Pharma Reports Fourth Quarter and Full Year 2023..
      2/07/202408:30GLOBEAscendis Pharma to Participate in the Oppenheimer 34th..
      1/31/202416:15GLOBEAscendis Pharma to Report Full Year 2023 Financial Results..
      1/31/202416:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/31/202416:01GLOBEAscendis Pharma Launches 2nd TransCon™ Product: YORVIPATH®..
      1/29/202408:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/29/202408:30GLOBENew Company Eyconis Formed to Develop Ascendis Pharma..
      1/10/202416:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202408:20GLOBEVector Pharma FZCO Announce Exclusive Distribution Agreement..
      1/08/202406:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202406:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/07/202417:45GLOBEAscendis Pharma Introduces Vision 2030
      1/07/202414:00PRNUSSpecialised Therapeutics signs exclusive agreement with..
      1/02/202406:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/28/202316:15GLOBEAscendis Pharma to Participate in the 42nd Annual J.P...
      12/20/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/20/202308:30GLOBESignificant Health and Quality of Life Improvements Achieved..
      12/19/202316:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/19/202308:30GLOBETransCon™ hGH (lonapegsomatropin) Achieved Statistically..
      12/13/202316:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/11/202308:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/11/202308:30GLOBEFDA Accepts for Review Resubmitted NDA for TransCon PTH..
      12/07/202314:53EDGAR2Form 144 - Report of proposed sale of securities
      12/05/202316:20EDGAR2Form 144 - Report of proposed sale of securities
      11/30/202315:44EDGAR2Form 144 - Report of proposed sale of securities

      Your Recent History

      NASDAQ
      ASND
      Ascendis Pharma AS
      Delayed Upgrade Clock